129 related articles for article (PubMed ID: 20724965)
21. Serious and invasive pediatric pneumococcal disease: epidemiology and vaccine impact in the USA.
Tan TQ
Expert Rev Anti Infect Ther; 2010 Feb; 8(2):117-25. PubMed ID: 20109042
[TBL] [Abstract][Full Text] [Related]
22. Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia?
Giele C; Moore H; Bayley K; Harrison C; Murphy D; Rooney K; Keil AD; Lehmann D
Vaccine; 2007 Mar; 25(13):2379-84. PubMed ID: 17064825
[TBL] [Abstract][Full Text] [Related]
23. Indirect effects of childhood pneumococcal vaccination on pneumococcal carriage among adults and older children in Australian Aboriginal communities.
Mackenzie G; Carapetis J; Leach AJ; Hare K; Morris P
Vaccine; 2007 Mar; 25(13):2428-33. PubMed ID: 17030493
[TBL] [Abstract][Full Text] [Related]
24. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
Reinert RR
Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
[TBL] [Abstract][Full Text] [Related]
25. Pneumococcal vaccines in India.
Dutta AK; Aggarwal A
Indian J Pediatr; 2001 Mar; 68 Suppl 1():S39-43. PubMed ID: 11411384
[No Abstract] [Full Text] [Related]
26. [Pneumococcal conjugate vaccine in children].
Lévy J; Swennen B
Rev Med Brux; 2004 Sep; 25(4):A219-22. PubMed ID: 15516044
[TBL] [Abstract][Full Text] [Related]
27. [Considerations on pediatric pneumococcal infection in Navarra].
Bernaola E; Herranz M; Clerigué N; Torroba L; Gil F; Gil-Setas A
Rev Esp Quimioter; 2007 Mar; 20(1):143-9. PubMed ID: 17530048
[No Abstract] [Full Text] [Related]
28. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS
Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392
[TBL] [Abstract][Full Text] [Related]
29. Experience with pneumococcal conjugate vaccine in Norway.
Aaberge IS
Expert Rev Vaccines; 2009 Feb; 8(2):159-65. PubMed ID: 19196196
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of pneumococcal conjugate vaccine in Greater Vancouver, Canada: 2004-2005.
Bjornson G; Scheifele DW; Bettinger J; Patrick DM; Gustafson L; Daly P; Tyrrell GJ
Pediatr Infect Dis J; 2007 Jun; 26(6):540-2. PubMed ID: 17529875
[TBL] [Abstract][Full Text] [Related]
31. Randomized, controlled trial efficacy of pneumococcal conjugate vaccine against otitis media among Navajo and White Mountain Apache infants.
O'Brien KL; David AB; Chandran A; Moulton LH; Reid R; Weatherholtz R; Santosham M
Pediatr Infect Dis J; 2008 Jan; 27(1):71-3. PubMed ID: 18162944
[TBL] [Abstract][Full Text] [Related]
32. Fever without source in children 0 to 36 months of age.
Ishimine P
Pediatr Clin North Am; 2006 Apr; 53(2):167-94. PubMed ID: 16574521
[TBL] [Abstract][Full Text] [Related]
33. Reduction of carriage and transmission of Streptococcus pneumoniae: the beneficial "side effect" of pneumococcal conjugate vaccine.
Azzari C; Resti M
Clin Infect Dis; 2008 Oct; 47(8):997-9. PubMed ID: 18781870
[No Abstract] [Full Text] [Related]
34. Vaccines for other neonatal infections: pneumococcal disease: a major global health problem of young children.
Richmond P
Expert Rev Vaccines; 2004 Aug; 3(4):379-82. PubMed ID: 15270639
[TBL] [Abstract][Full Text] [Related]
35. [Conjugated pneumococcal vaccine: a clinical profile].
Di Virgilio R; Zollo A
Ann Ig; 2001; 13(4 Suppl 3):39-42. PubMed ID: 11760435
[No Abstract] [Full Text] [Related]
36. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
37. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
[TBL] [Abstract][Full Text] [Related]
38. Pneumococcal vaccination: effective in children under the age of 2 years.
Prescrire Int; 2009 Dec; 18(104):266. PubMed ID: 20027709
[TBL] [Abstract][Full Text] [Related]
39. Prevention of pneumococcal disease among adults.
Maxim RB
Med Health R I; 2001 May; 84(5):174-5. PubMed ID: 11392959
[No Abstract] [Full Text] [Related]
40. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.
Lloyd A; Patel N; Scott DA; Runge C; Claes C; Rose M
Eur J Health Econ; 2008 Feb; 9(1):7-15. PubMed ID: 17333089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
